New surgical approach aims to spare nerves and improve life for GERD patients

NCT ID NCT07252115

Recruiting now Disease control Sponsor: Beijing Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new nerve-sparing surgery (TLSA) to the standard surgery for people with hiatal hernia and GERD. The goal is to see if the new approach improves quality of life by avoiding damage to a key nerve. About 143 adults will take part in this randomized trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Total left-side surgical approach (TLSA) - a nerve-sparing laparoscopic procedure
What this could lead to: If successful, this surgical technique could reduce side effects like swallowing problems and improve quality of life for people with hiatal hernia and GERD.
What could go wrong: This is a relatively small, early-stage trial. The new approach may not prove better than the standard surgery, and all surgeries carry risks like infection or nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease hiatus hernia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERD (GASTROESOPHAGEAL REFLUX DISEASE) HERNIA, HIATAL

Contacts and locations

Locations

Beijing Friendship Hospital
ACTIVE_NOT_RECRUITING

Beijing, 100050, China
Beijing Friendship Hospital
RECRUITING

Beijing, 100050, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.